La cadena de opciones muestra datos clave de las opciones de acciones de Syntec Optics Holdings a varios precios de ejercicio y fechas de vencimiento. Los operadores utilizan esta información para analizar posibles operaciones y evaluar el sentimiento del mercado para Syntec Optics Holdings..

Syntec Optics Holdings (NASDAQ:OPTX) Bolsa, Cadena de Opciones

Syntec Optics Holdings

Syntec Optics Holdings Inc is vertically integrated from design and component manufacturing for lens system assembly to imaging module integration for system solutions. Making its tools, molding, and nano machining allows close interaction and recut ability, enabling special techniques to hold tolerances to sub-micron levels. It has steadily developed a variety of other complementary manufacturing techniques to provide a wide suite of horizontal capabilities including thin film deposition coatings, glass molding, polymer molding, tool-making, mechanical manufacturing, and nano machining.

Syntec Optics Holdings, Inc. - Class A Common Stock

Syntec Optics Holdings Inc

The latest announcement is out from Syntec Optics Holdings (OPTX). Syntec Optics Holdings, Inc. has appointed Dean Rudy as the new Chief Financial ...

Syntec Optics Holdings Announces CFO Transition and Growth Strategy

Syntec Optics secures $1.3M orders for microlens array, forecasts more orders of $3.2M

<p><a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a></p>
<p>It&rsquo;s time to dive into the biggest pre-market stock movers as we check out all of the latest news happening on Wednesday morning!</p>



<p>Moving stocks this morning are patent news, a new investment, proposed public offerings and more.</p>



<p>Let&rsquo;s get into that news below!</p>



<h2>Biggest Pre-Market Stock Movers: 10 Top Gainers</h2>



<ol><li><strong>Syntec Optics</strong> (NASDAQ:<a href="https://investorplace.com/stock-quotes/optx-stock-quote/"><strong>OPTX</strong></a>) stock is rocketing more than 248% alongside heavy pre-market trading.</li>



<li><strong>Anew Medical</strong> (NASDAQ:<a href="https://investorplace.com/stock-quotes/wena-stock-quote/"><strong>WENA</strong></a>) shares are soaring over 75% after <a href="https://www.nasdaq.com/press-release/anew-medical-inc-secures-key-patent-europe-human-klotho-gene-rna-slice-variant-and">securing a key patent in Europe</a>.</li>



<li><strong>Volcon </strong>(NASDAQ:<a href="https://investorplace.com/stock-quotes/vlcn-stock-quote/"><strong>VLCN</strong></a>) stock is surging more than 36% as it <a href="https://investorplace.com/2024/06/why-is-volcon-vlcn-stock-up-60-today/">continues yesterday&rsquo;s rally</a>.</li>



<li><strong>Rivian Automotive</strong> (NASDAQ:<a href="https://investorplace.com/stock-quotes/rivn-stock-quote/"><strong>RIVN</strong></a>) shares are gaining over 36% on a <a href="https://www.nytimes.com/2024/06/25/business/volkswagen-rivian-vw-investment.html">$5 billion investment</a>.</li>



<li><strong>China Natural Resources</strong> (NASDAQ:<a href="https://investorplace.com/stock-quotes/chnr-stock-quote/"><strong>CHNR</strong></a>) stock is increasing more than 32% with strong trading this morning.</li>



<li><strong>Savara </strong>(NASDAQ:<a href="https://investorplace.com/stock-quotes/svra-stock-quote/"><strong>SVRA</strong></a>) shares are rising over 26% on a <a href="https://seekingalpha.com/news/4119362-savara-stock-surges-trial-win-lead-asset?source=content_type%3Areact%7Cfirst_level_url%3Amarket-news%7Csection_asset%3Amain">positive clinical trial</a>.</li>



<li><strong>Talphera</strong> (NASDAQ:<a href="https://investorplace.com/stock-quotes/tlph-stock-quote/"><strong>TLPH</strong></a>) stock is heading more than 21% higher on Wednesday morning.</li>



<li><strong>eFFECTOR Therapeutics</strong> (NASDAQ:<a href="https://investorplace.com/stock-quotes/eftr-stock-quote/"><strong>EFTR</strong></a>) shares are climbing over 18% even as it plans to <a href="https://finance.yahoo.com/news/effector-therapeutics-announces-wind-down-110000717.html">wind down operations</a>.</li>



<li><strong>Golden Matrix</strong> (NASDAQ:<a href="https://investorplace.com/stock-quotes/gmgi-stock-quote/"><strong>GMGI</strong></a>) stock is jumping more than 15% today.</li>



<li><strong>Faraday Future</strong> (NASDAQ:<a href="https://investorplace.com/stock-quotes/ffie-stock-quote/"><strong>FFIE</strong></a>) shares are up over 14% <a href="https://investorplace.com/2024/06/faraday-future-stock-shocker-from-ev-maker-to-china-u-s-auto-middleman/">on survival plans</a>.</li>
</ol><h2>10 Top Losers</h2>



<ol><li><strong>NextTrip </strong>(NASDAQ:<a href="https://investorplace.com/stock-quotes/ntrp-stock-quote/"><strong>NTRP</strong></a>) stock is diving more than 24% without any recent news to report.</li>



<li><strong>GRI Bio</strong> (NASDAQ:<a href="https://investorplace.com/stock-quotes/gri-stock-quote/"><strong>GRI</strong></a>) shares are tumbling over 15% on a <a href="https://app.quotemedia.com/data/downloadFiling?webmasterId=90423&amp;ref=318415310&amp;type=PDF&amp;symbol=GRI&amp;cdn=40db9b65c5660c095bf51f08f72c725f&amp;companyName=GRI+Bio+Inc.&amp;formType=S-1%2FA&amp;formDescription=%5BAmend%5D+General+form+for+registration+of+securities+under+the+Securities+Act+of+1933&amp;dateFiled=2024-06-26">proposed public offering</a>.</li>



<li><strong>Taysha Gene Therapies</strong> (NASDAQ:<a href="https://investorplace.com/stock-quotes/tsha-stock-quote/"><strong>TSHA</strong></a>) stock is taking a 14% beating on <a href="https://www.nasdaq.com/press-release/taysha-gene-therapies-announces-proposed-public-offering-common-stock-and-pre-funded">public offering plans</a>.</li>



<li><strong>Oblong </strong>(NASDAQ:<a href="https://investorplace.com/stock-quotes/oblg-stock-quote/"><strong>OBLG</strong></a>) shares are sliding more than 12% despite a lack of news this morning.</li>



<li><strong>Hanryu </strong>(NASDAQ:<a href="https://investorplace.com/stock-quotes/hryu-stock-quote/"><strong>HRYU</strong></a>) stock is decreasing over 11% on Wednesday.</li>



<li><strong>Hamilton Beach Brands</strong> (NYSE:<a href="https://investorplace.com/stock-quotes/hbb-stock-quote/"><strong>HBB</strong></a>) shares are dropping more than 10% today.</li>



<li><strong>GlycoMimetics </strong>(NASDAQ:<a href="https://investorplace.com/stock-quotes/glyc-stock-quote/"><strong>GLYC</strong></a>) stock is falling over 10% <a href="https://finance.yahoo.com/news/senior-vp-chief-medical-officer-100744620.html">despite insider buying</a>.</li>



<li><strong>Geovax Labs </strong>(NASDAQ:<a href="https://investorplace.com/stock-quotes/govx-stock-quote/"><strong>GOVX</strong></a>) shares are slipping more than 9% today.</li>



<li><strong>Concord Medical Services</strong> (NYSE:<a href="https://investorplace.com/stock-quotes/ccm-stock-quote/"><strong>CCM</strong></a>) stock is dipping over 9% this morning.</li>



<li><strong>DermTech </strong>(NASDAQ:<a href="https://investorplace.com/stock-quotes/dmtk-stock-quote/"><strong>DMTK</strong></a>) shares close out our pre-market stock movers down more than 9% as they <a href="https://app.quotemedia.com/data/downloadFiling?webmasterId=90423&amp;ref=318404814&amp;type=PDF&amp;symbol=DMTK&amp;cdn=2f95604b7d0b2db1ef0d52c1cc04ae14&amp;companyName=DermTech+Inc&amp;formType=8-K&amp;formDescription=Current+report+pursuant+to+Section+13+or+15%28d%29&amp;dateFiled=2024-06-20">prepare for delisting tomorrow</a>.</li>
</ol><p><em>On the date of publication, William White did not have (either directly or indirectly) any positions in the securities mentioned in this article. The opinions expressed in this article are those of the writer, subject to the&nbsp;InvestorPlace.com&nbsp;</em><a href="https://investorplace.com/corporate/investorplace-publishing-guidelines/" target="_blank"><em>Publishing Guidelines</em></a><em>.</em></p>
<h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2023/10/no-1-ai-investment-might-be-this-company-youve-never-heard-of/?cid=MKT764787&amp;eid=MKT802110">The #1 AI Investment Might Be This Company You&rsquo;ve Never Heard Of</a>
					</li>
																<li>
						<a href="https://investorplace.com/2023/07/elon-musks-project-omega-stuns-silicon-valley-insiders/?cid=MKT738510&amp;eid=MKT766411">Musk&rsquo;s &ldquo;Project Omega&rdquo; May Be Set to Mint New Millionaires. Here&rsquo;s How to Get In.</a>
					</li>
																<li>
						<a href="https://investorplace.com/2024/04/legendary-investor-predicts-forget-a-i-this-technology-is-the-future/?cid=MKT794457&amp;eid=MKT802109">Legendary Investor Predicts: &ldquo;Forget A.I. THIS Technology Is the Future&rdquo;</a>
					</li>
									</ul><div>
			<div></div>
						<div></div>
					</div>
	<p>The post <a href="https://investorplace.com/2024/06/todays-biggest-pre-market-stock-movers-10-top-gainers-and-losers-on-wednesday-june-26th/">Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.</p>

Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday

<p><a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a></p>
<p><strong>Anew Medical</strong>&nbsp;(NASDAQ:<a href="https://investorplace.com/stock-quotes/wena-stock-quote/"><strong>WENA</strong></a>) stock is taking off on Wednesday after the biologic medicines company announced it has <a href="https://www.nasdaq.com/press-release/anew-medical-inc-secures-key-patent-europe-human-klotho-gene-rna-slice-variant-and">secured a key patent in Europe</a>.</p>



<p>This patent is connected to Anew Medical&rsquo;s secreted Klotho gene sequence and gene delivery systems. These will be used to treat diminished cognition, memory loss, dementia, as well as other neurodegenerative diseases.</p>



<p>Anew Medical says it secured this patent after licensing the treatment from Universitat Aut&ograve;noma de&nbsp;Barcelona&nbsp;(UAB) and Instituci&oacute; Catalana de Recerca i Estudis Avan&ccedil;ats (ICREA). It also secured a similar patent for it in China on May 4, 2024.</p>



<p>Anew Medical founder and CEO Dr. Joseph Sinkule said the following about this news.</p>




<p>&ldquo;We feel strongly about the significant potential of this therapy and have taken meticulous steps to protect and expand our licensed intellectual property in major global markets. These assets play a vital role in our international product development efforts for neurodegenerative diseases, including Alzheimer&rsquo;s, Parkinson&rsquo;s, Huntington&rsquo;s, and ALS (Lou Gehrig&rsquo;s disease).&rdquo;</p>




<h2>WENA Stock Movement on Wednesday</h2>



<p>With this latest patent news comes heavy trading of WENA shares. That has more than 16.6 million trading hands as of this writing. This is well above the company&rsquo;s daily average trading volume of about 217,000 shares.</p>



<p>WENA stock is up 144.2% as of Wednesday morning.</p>



<p>Investors will want to stick around for more of the most recent stock market stories today!</p>



<p>We have all of the hottest stock market news traders need to know about on Wednesday! A mong that is what has shares of <strong>Syntec Optics</strong>&nbsp;(NASDAQ:<a href="https://investorplace.com/stock-quotes/optx-stock-quote/"><strong>OPTX</strong></a>) stock up, the biggest pre-market stock movers and more. All of that info is good to go at the links below!</p>



<h2>More Stock Market News for Wednesday</h2>



<ul><li><a href="https://investorplace.com/2024/06/why-is-syntec-optics-optx-stock-up-186-today/">Why Is Syntec Optics (OPTX) Stock Up 186% Today?</a></li>



<li><a href="https://investorplace.com/2024/06/todays-biggest-pre-market-stock-movers-10-top-gainers-and-losers-on-wednesday-june-26th/">Today&rsquo;s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on&nbsp;Wednesday</a></li>



<li><a href="https://investorplace.com/2024/06/orcl-stock-alert-is-a-tiktok-ban-enough-to-kill-oracle/">ORCL Stock Alert: Is a TikTok Ban Enough to Kill Oracle?</a></li>
</ul><p><em><strong>On Penny Stocks and Low-Volume Stocks:</strong>&#8239;With only the rarest exceptions, InvestorPlace does not publish commentary about companies that have a market cap of less than $100 million or trade less than 100,000 shares each day. That&rsquo;s because these &ldquo;penny stocks&rdquo; are frequently the playground for scam artists and market manipulators. If we ever do publish commentary on a low-volume stock that may be affected by our commentary, we demand that&#8239;InvestorPlace.com&rsquo;s writers disclose this fact and warn readers of the risks.</em></p>



<p><em><strong>Read More:</strong>&#8239;Penny Stocks &mdash;&nbsp;</em><a href="https://investorplace.com/2014/05/fraud-penny-stocks-scams/" target="_blank"><em>How to Profit Without Getting Scammed</em></a></p>



<p><em>On the date of publication, William White did not have (either directly or indirectly) any positions in the securities mentioned in this article. The opinions expressed in this article are those of the writer, subject to the&nbsp;InvestorPlace.com&nbsp;</em><a href="https://investorplace.com/corporate/investorplace-publishing-guidelines/" target="_blank"><em>Publishing Guidelines</em></a><em>.</em></p>
<h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2023/10/no-1-ai-investment-might-be-this-company-youve-never-heard-of/?cid=MKT764787&amp;eid=MKT802110">The #1 AI Investment Might Be This Company You&rsquo;ve Never Heard Of</a>
					</li>
																<li>
						<a href="https://investorplace.com/2023/07/elon-musks-project-omega-stuns-silicon-valley-insiders/?cid=MKT738510&amp;eid=MKT766411">Musk&rsquo;s &ldquo;Project Omega&rdquo; May Be Set to Mint New Millionaires. Here&rsquo;s How to Get In.</a>
					</li>
																<li>
						<a href="https://investorplace.com/2024/04/legendary-investor-predicts-forget-a-i-this-technology-is-the-future/?cid=MKT794457&amp;eid=MKT802109">Legendary Investor Predicts: &ldquo;Forget A.I. THIS Technology Is the Future&rdquo;</a>
					</li>
									</ul><div>
			<div></div>
						<div></div>
					</div>
	<p>The post <a href="https://investorplace.com/2024/06/why-is-anew-medical-wena-stock-up-144-today/">Why Is Anew Medical (WENA) Stock Up 144% Today?</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.</p>

Why Is Anew Medical (WENA) Stock Up 144% Today?

<p><a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a></p>
<p><strong>Syntec Optics</strong>&nbsp;(NASDAQ:<a href="https://investorplace.com/stock-quotes/optx-stock-quote/"><strong>OPTX</strong></a>) stock is rocketing higher on Wednesday alongside heavy pre-market trading of the optics and photonics components company&rsquo;s shares.</p>



<p>This has more than 4.6 million shares of OPTX stock changing hands as of this writing. That&rsquo;s a major increase compared to its daily average trading volume of about 6,500 shares. It&rsquo;s also worth noting that the company&rsquo;s <a href="https://finance.yahoo.com/quote/OPTX/key-statistics/">float is 6.06 million units</a>.</p>



<p>This heavy trading of OPTX stock comes without any clear news from the company. That includes a lack of press releases or filings with the Securities and Exchange Commission (SEC) today. There&rsquo;s also no analyst coverage that would act as a catalyst for today&rsquo;s rally.</p>



<p>What we do want to keep in mind is that OPTX is a penny stock. This comes from its low daily average trading volume, prior closing price of $2.35 per share and its market capitalization of $86.218 million.</p>



<h2>What That Means for OPTX Stock</h2>



<p>Being a penny stock comes with certain issues. That includes volatility as the shares are easy to manipulate. It could also be a case of speculative traders taking a stake in the business.</p>



<p>No matter the case, the increase without new should be a warning to investors. It&rsquo;s unlikely that shares of OPTX stock will remain that high for long. This could leave some unfortunate traders left holding the bag.</p>



<p>OPTX stock is up 185.6% as of Wednesday morning.</p>



<p>Investors will want to keep reading for more of the latest stock market news today!</p>



<p>We have all of the hottest stock market stories ready to go on Wednesday! That includes the biggest pre-market stock movers this morning and more of the most recent news. All of that is ready to go at the links below!</p>



<h2>More Wednesday Stock Market News</h2>



<ul><li><a href="https://investorplace.com/2024/06/todays-biggest-pre-market-stock-movers-10-top-gainers-and-losers-on-wednesday-june-26th/">Today&rsquo;s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on&nbsp;Wednesday</a></li>



<li><a href="https://investorplace.com/2024/06/orcl-stock-alert-is-a-tiktok-ban-enough-to-kill-oracle/">ORCL Stock Alert: Is a TikTok Ban Enough to Kill Oracle?</a></li>



<li><a href="https://investorplace.com/2024/06/dear-trump-media-djt-stock-fans-mark-your-calendars-for-june-27/">Dear Trump Media (DJT) Stock Fans, Mark Your Calendars for June 27</a></li>
</ul><p><em><strong>On Penny Stocks and Low-Volume Stocks:</strong>&#8239;With only the rarest exceptions, InvestorPlace does not publish commentary about companies that have a market cap of less than $100 million or trade less than 100,000 shares each day. That&rsquo;s because these &ldquo;penny stocks&rdquo; are frequently the playground for scam artists and market manipulators. If we ever do publish commentary on a low-volume stock that may be affected by our commentary, we demand that&#8239;InvestorPlace.com&rsquo;s writers disclose this fact and warn readers of the risks.</em></p>



<p><em><strong>Read More:</strong>&#8239;Penny Stocks &mdash;&nbsp;</em><a href="https://investorplace.com/2014/05/fraud-penny-stocks-scams/" target="_blank"><em>How to Profit Without Getting Scammed</em></a></p>



<p><em>On the date of publication, William White did not have (either directly or indirectly) any positions in the securities mentioned in this article. The opinions expressed in this article are those of the writer, subject to the&nbsp;InvestorPlace.com&nbsp;</em><a href="https://investorplace.com/corporate/investorplace-publishing-guidelines/" target="_blank"><em>Publishing Guidelines</em></a><em>.</em></p>
<h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2023/10/no-1-ai-investment-might-be-this-company-youve-never-heard-of/?cid=MKT764787&amp;eid=MKT802110">The #1 AI Investment Might Be This Company You&rsquo;ve Never Heard Of</a>
					</li>
																<li>
						<a href="https://investorplace.com/2023/07/elon-musks-project-omega-stuns-silicon-valley-insiders/?cid=MKT738510&amp;eid=MKT766411">Musk&rsquo;s &ldquo;Project Omega&rdquo; May Be Set to Mint New Millionaires. Here&rsquo;s How to Get In.</a>
					</li>
																<li>
						<a href="https://investorplace.com/2024/04/legendary-investor-predicts-forget-a-i-this-technology-is-the-future/?cid=MKT794457&amp;eid=MKT802109">Legendary Investor Predicts: &ldquo;Forget A.I. THIS Technology Is the Future&rdquo;</a>
					</li>
									</ul><div>
			<div></div>
						<div></div>
					</div>
	<p>The post <a href="https://investorplace.com/2024/06/why-is-syntec-optics-optx-stock-up-186-today/">Why Is Syntec Optics (OPTX) Stock Up 186% Today?</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.</p>

Why Is Syntec Optics (OPTX) Stock Up 186% Today?

<p><a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a></p>
<p><strong>GRI Bio</strong>&nbsp;(NASDAQ:<a href="https://investorplace.com/stock-quotes/gri-stock-quote/"><strong>GRI</strong></a>) stock is falling on Wednesday after the clinical-stage biopharmaceutical company announced a <a href="https://app.quotemedia.com/data/downloadFiling?webmasterId=90423&amp;ref=318415310&amp;type=PDF&amp;symbol=GRI&amp;cdn=40db9b65c5660c095bf51f08f72c725f&amp;companyName=GRI+Bio+Inc.&amp;formType=S-1%2FA&amp;formDescription=%5BAmend%5D+General+form+for+registration+of+securities+under+the+Securities+Act+of+1933&amp;dateFiled=2024-06-26">proposed public offering</a> for its shares.</p>



<p>GRI Bio plans to offer up to 2,238,806 shares of GRI stock. Each of these shares comes with one Series C-1 warrant and one Series C-2 warrant. Each of these can be exercised for another share of GRI.</p>



<p>GRI Bio doesn&rsquo;t have a firm price ready for its public offering just yet. Instead, it&rsquo;s operating off of an assumed price of $2.68 per share. This is also the price it currently has set for the exercise of its warrants.</p>



<p>GRI Bio also notes that the Series C-1 warrants will expire five years after being issued. The Series C-2 warrants are set to expire 18 months after being issued. The company is also offering up to 2,238,806 pre-funded warrants for investors who would see their stakes surpass 4.99% if they bought more shares.</p>



<h2>What This Means for GRI Stock</h2>



<p>A public offering increases the total number of outstanding shares on the market. At the same time, that dilutes the stakes of current shareholders in the company. That&rsquo;s one reason why GRI stock is down today.</p>



<p>On top of that, public offerings are typically priced below the stock&rsquo;s current value. This discount usually affects the stock&rsquo;s trading price. While the company hasn&rsquo;t priced shares in this offering yet, investors are still expecting a discount.</p>



<p>GRI stock is down 29.3% as of Wednesday morning.</p>



<p>Investors will want to keep reading for all of the hottest stock market news today!</p>



<p>We have all of the latest stock market stories available on Wednesday! A few examples include why shares of <strong>Anew Medical</strong>&nbsp;(NASDAQ:<a href="https://investorplace.com/stock-quotes/wena-stock-quote/"><strong>WENA</strong></a>) and <strong>Syntec Optics</strong>&nbsp;(NASDAQ:<a href="https://investorplace.com/stock-quotes/optx-stock-quote/"><strong>OPTX</strong></a>) stock are up, as well as the biggest pre-market stock movers this morning. All of this info is ready at the following links!</p>



<h2>More Wednesday Stock Market News</h2>



<ul><li><a href="https://investorplace.com/2024/06/why-is-anew-medical-wena-stock-up-144-today/">Why Is Anew Medical (WENA) Stock Up 144% Today?</a></li>



<li><a href="https://investorplace.com/2024/06/why-is-syntec-optics-optx-stock-up-186-today/">Why Is Syntec Optics (OPTX) Stock Up 186% Today?</a></li>



<li><a href="https://investorplace.com/2024/06/todays-biggest-pre-market-stock-movers-10-top-gainers-and-losers-on-wednesday-june-26th/">Today&rsquo;s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on&nbsp;Wednesday</a></li>
</ul><p><em><strong>On Penny Stocks and Low-Volume Stocks:</strong>&#8239;With only the rarest exceptions, InvestorPlace does not publish commentary about companies that have a market cap of less than $100 million or trade less than 100,000 shares each day. That&rsquo;s because these &ldquo;penny stocks&rdquo; are frequently the playground for scam artists and market manipulators. If we ever do publish commentary on a low-volume stock that may be affected by our commentary, we demand that&#8239;InvestorPlace.com&rsquo;s writers disclose this fact and warn readers of the risks.</em></p>



<p><em><strong>Read More:</strong>&#8239;Penny Stocks &mdash;&nbsp;</em><a href="https://investorplace.com/2014/05/fraud-penny-stocks-scams/" target="_blank"><em>How to Profit Without Getting Scammed</em></a></p>



<p><em>On the date of publication, William White did not have (either directly or indirectly) any positions in the securities mentioned in this article. The opinions expressed in this article are those of the writer, subject to the&nbsp;InvestorPlace.com&nbsp;</em><a href="https://investorplace.com/corporate/investorplace-publishing-guidelines/" target="_blank"><em>Publishing Guidelines</em></a><em>.</em></p>
<h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2023/10/no-1-ai-investment-might-be-this-company-youve-never-heard-of/?cid=MKT764787&amp;eid=MKT802110">The #1 AI Investment Might Be This Company You&rsquo;ve Never Heard Of</a>
					</li>
																<li>
						<a href="https://investorplace.com/2023/07/elon-musks-project-omega-stuns-silicon-valley-insiders/?cid=MKT738510&amp;eid=MKT766411">Musk&rsquo;s &ldquo;Project Omega&rdquo; May Be Set to Mint New Millionaires. Here&rsquo;s How to Get In.</a>
					</li>
																<li>
						<a href="https://investorplace.com/2024/04/legendary-investor-predicts-forget-a-i-this-technology-is-the-future/?cid=MKT794457&amp;eid=MKT802109">Legendary Investor Predicts: &ldquo;Forget A.I. THIS Technology Is the Future&rdquo;</a>
					</li>
									</ul><div>
			<div></div>
						<div></div>
					</div>
	<p>The post <a href="https://investorplace.com/2024/06/why-is-gri-bio-gri-stock-down-29-today/">Why Is GRI Bio (GRI) Stock Down 29% Today?</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.</p>

Why Is GRI Bio (GRI) Stock Down 29% Today?

<p><a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a></p>
<p><strong>Taysha Gene Therapies</strong>&nbsp;(NASDAQ:<a href="https://investorplace.com/stock-quotes/tsha-stock-quote/"><strong>TSHA</strong></a>) stock is taking a beating on Wednesday after the gene therapy company announced a <a href="https://www.nasdaq.com/press-release/taysha-gene-therapies-announces-proposed-public-offering-common-stock-and-pre-funded">proposed public offering</a> for its shares.</p>



<p>Taysha Gene Therapies says that it intends to offer up to $75 million worth of TSHA stock in this offering. The company hasn&rsquo;t nailed down how many shares will be included or what they will be priced at.</p>



<p>What we do know is that it also intends to offer pre-funded warrants for certain investors. On top of that, underwriters have a 30-day option to acquire an additional 15% of shares included in the offering.</p>



<p>Jefferies and Goldman Sachs &amp; Co. LLC are serving as joint book-running managers for the public offering. Cantor is acting as a book-running manager for it as well.</p>



<h2>How This Affects TSHA Stock</h2>



<p>With this public offering will come an increase in the number of TSHA shares on the market. Doing this dilutes the stakes of current investors in the company. That&rsquo;s one of the reasons why the shares are falling today.</p>



<p>On top of that, the pricing of the offering may upset investors. It&rsquo;s expected to be discounted compared to the company&rsquo;s prior closing price. If so, that will likely have a further negative effect on the company&rsquo;s shares.</p>



<p>TSHA stock is down 14% as of Wednesday morning.</p>



<p>There are plenty of other stock market stories traders are going to want to read about today!</p>



<p>We have all of the hottest stock market stories ready to go on Wednesday! That includes all of the latest news from <strong>GRI Bio</strong>&nbsp;(NASDAQ:<a href="https://investorplace.com/stock-quotes/gri-stock-quote/"><strong>GRI</strong></a>), <strong>Anew Medical</strong>&nbsp;(NASDAQ:<a href="https://investorplace.com/stock-quotes/wena-stock-quote/"><strong>WENA</strong></a>) and <strong>Syntec Optics</strong>&nbsp;(NASDAQ:<a href="https://investorplace.com/stock-quotes/optx-stock-quote/"><strong>OPTX</strong></a>). You can read up on all of these matters at the following links!</p>



<h2>More Stock Market News for Wednesday</h2>



<ul><li><a href="https://investorplace.com/2024/06/why-is-gri-bio-gri-stock-down-29-today/">Why Is GRI Bio (GRI) Stock Down 29% Today?</a></li>



<li><a href="https://investorplace.com/2024/06/why-is-anew-medical-wena-stock-up-144-today/">Why Is Anew Medical (WENA) Stock Up 144% Today?</a></li>



<li><a href="https://investorplace.com/2024/06/why-is-syntec-optics-optx-stock-up-186-today/">Why Is Syntec Optics (OPTX) Stock Up 186% Today?</a></li>
</ul><p><em>On the date of publication, William White did not have (either directly or indirectly) any positions in the securities mentioned in this article. The opinions expressed in this article are those of the writer, subject to the&nbsp;InvestorPlace.com&nbsp;</em><a href="https://investorplace.com/corporate/investorplace-publishing-guidelines/" target="_blank"><em>Publishing Guidelines</em></a><em>.</em></p>
<h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2023/10/no-1-ai-investment-might-be-this-company-youve-never-heard-of/?cid=MKT764787&amp;eid=MKT802110">The #1 AI Investment Might Be This Company You&rsquo;ve Never Heard Of</a>
					</li>
																<li>
						<a href="https://investorplace.com/2023/07/elon-musks-project-omega-stuns-silicon-valley-insiders/?cid=MKT738510&amp;eid=MKT766411">Musk&rsquo;s &ldquo;Project Omega&rdquo; May Be Set to Mint New Millionaires. Here&rsquo;s How to Get In.</a>
					</li>
																<li>
						<a href="https://investorplace.com/2024/04/legendary-investor-predicts-forget-a-i-this-technology-is-the-future/?cid=MKT794457&amp;eid=MKT802109">Legendary Investor Predicts: &ldquo;Forget A.I. THIS Technology Is the Future&rdquo;</a>
					</li>
									</ul><div>
			<div></div>
						<div></div>
					</div>
	<p>The post <a href="https://investorplace.com/2024/06/why-is-taysha-gene-therapies-tsha-stock-down-14-today/">Why Is Taysha Gene Therapies (TSHA) Stock Down 14% Today?</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.</p>

Why Is Taysha Gene Therapies (TSHA) Stock Down 14% Today?

<p><a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a></p>
<p><strong>Syntec Optics Holdings</strong> (NASDAQ:<span><a href="https://investorplace.com/stock-quotes/optx-stock-quote/"><strong>OPTX</strong></a></span>) just reported results for the second quarter of 2024.</p><ul><li>Syntec Optics Holdings reported earnings per share of 1 cent.</li><li>The company reported revenue of $7.01 million.</li></ul><div><p>InvestorPlace Earnings is a project that leverages data from <a href="https://www.tradesmith.com">TradeSmith</a> to automate coverage of quarterly earnings reports. InvestorPlace Earnings distills key takeaways including earnings per share and revenue, as well as how a company stacks up to analyst estimates. These articles are published without human intervention, allowing us to inform our readers of the latest figures as quickly as possible. To report any concerns or inaccuracies, please contact us at <a href="mailto:editor@investorplace.com">editor@investorplace.com</a>.</p></div><h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2024/04/legendary-investor-predicts-forget-a-i-this-technology-is-the-future/?cid=MKT794457&amp;eid=MKT802109">Legendary Investor Predicts: &ldquo;Forget AI... THIS Technology Is the Future&rdquo;</a>
					</li>
									</ul><p>The post <a href="https://investorplace.com/earning-results/2024/08/optx-stock-earnings-syntec-optics-holdings-for-q2-of-2024/">OPTX Stock Earnings: Syntec Optics Holdings Reported Results for Q2 2024</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.</p>

OPTX Stock Earnings: Syntec Optics Holdings Reported Results for Q2 2024

Syntec Optics looks to resume production for precision laser guidance optics

Syntec Optics (OPTX) is planning to restart the manufacturing of components and assembly that supports the precision-guided munition program in Mar...

Syntec Optics plans to restart production for precision laser guidance optics

CHNR

DMTK

EFTR

FFIE

GLYC

GMGI

GOVX

HRYU

NTRP

OBLG

OPTX

RIVN

SVRA

TLPH

TSHA

VLCN

WENA

Markets

Press Releases

General

Syntec Optics (Nasdaq: OPTX) Secures $1.3M Orders for Datacom Microlens Array, Orders Forecasted to More Than Double to $3.2M

Syntec Optics (Nasdaq: OPTX) Builds Higher Volume Manufacturing Cells for Low Earth Orbit Satellite Optics and Data Center Optical Connectivity Product Lines

Syntec Optics (Nasdaq: OPTX) to Manufacture over $1M in Advanced Optics for Next Generation U.S. Defense Integrated Optics System

Syntec Optics (Nasdaq: OPTX) Secures $2.2M in New Orders for Space Optics

Syntec Optics (Nasdaq: OPTX) Launches Production of New Disposable Optics for Characterization of Biomolecules and Nanoparticles

Earnings

Syntec Optics (Nasdaq: OPTX) to Host Conference Call to Discuss Financial Results and Business Update

Syntec Optics Holdings, Inc. (Nasdaq: OPTX) Reports Second Quarter 2024 Financial Results

News

Syntec Optics (Nasdaq: OPTX) Chairman & CEO to Keynote the Future of Photonics that Enables the Tech Frontier from Artificial Intelligence to Quantum and Defense

Syntec Optics (Nasdaq: OPTX) Plans to Restart Production for Precision Laser Guidance Optics for Next Five Years

Syntec Optics Holdings, Inc. (Nasdaq: OPTX) Reports Third Quarter 2024 Financial Results

Comments

Syntec Optics Holdings

Syntec Optics Holdings (OPTX) Opciones

No option chain data available. Please try again later

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL